1. Dao KH, Bermas BL. Systemic Lupus Erythematosus Management in Pregnancy. Int J Womens Health. 2022; 14: 199-211.
2. Choi J, Kim ST, Craft J. The Pathogenesis of Systemic Lupus Erythematosus: An Update. Curr Opin Immunol. 2012; 24(6): 651-7.
3. Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. Diagnostic Criteria for Systemic Lupus Erythematosus: Has the Time Come. Nat Rev Rheumatol. 2013; 9(11): 687-94.
4. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Ann Rheum Dis. 2019; 78(9): 1151-9.
5. Gergianaki I, Bortoluzzi A, Bertsias G. Update on the Epidemiology, Risk Factors, and Disease Outcomes of Systemic Lupus Erythematosus. Best Pract Res Clin Rheumatol. 2018; 32(2): 188-205.
6. Stojan G, Petri M. Epidemiology of Systematic Lupus Erythematosus: An Update. Curr Opin Rheumatol. 2018; 30(2): 144-50.
7. Petri M. Pregnancy and Systemic Lupus Erythematosus. Best Pract Res Clin Obstet Gynaecol. 2020 Apr;64:24-30. doi: 10.1016/j.bpobgyn.2019.09.002.
8. Tedeschi SK, Bermas B, Costenbader KH. Sexual Disparities in the Incidence and Course of LES and RA. Clin Immunol. 2013; 149(2): 211-8.
9. Dalal DS, Patel KA, Patel MA. Systemic Lupus Erythematosus and Pregnancy: A Brief Review. J Obstet Gynaecol India. 2019 Apr;69(2):104-109. doi: 10.1007/s13224-019-01212-8.
10. Clowse MEB, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of Infertility, Pregnancy Loss, and Patient Concerns on Family Size of Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus. Arthritis Care Res. 2012; 64(5): 668-74.
11. Ma W, Zhan Z, Liang X, Chen J, Huang X, Liao C. Subclinical Impairment of Ovarian Reserve in Systemic Lupus Erythematosus Patients with Normal Menstruation Not Using Alkylating Therapy. J Womens Health. 2013; 22(12): 1023-27.
12. Nguyen QN, Zerafa N, Liew SH, Findlay JK, Hickey M, Hutt KJ. Cisplatin- and Cyclophosphamide-Induced Primordial Follicle Depletion is Caused by Direct Damage to Oocytes. Mol Hum Reprod. 2019; 25(8): 433-44.
13. Perhimpunan Reumatologi Indonesia (IRA). Rekomendasi Perhimpunan Reumatologi Indonesia: Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. 2019. Jakarta: IRA.
14. Knight CL, Nelson-Piercy C. Management of Systemic Lupus Erythematosus during Pregnancy: Challenges and Solutions. Open Access Rheumatol. 2017; 10(9): 37-53.
15. Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, et al. EULAR Recommendations for Women’s Health and the Management of Family Planning, Assisted Reproduction, Pregnancy, and Menopause in Patients with Systematic Lupus Erythematosus and/or Antiphospholipid Syndrome. Ann Rheum Dis. 2017; 76(3): 476-85.
16. Yamamoto Y, Aoki S. Systemic Lupus Erythematosus: Strategies to Improve Pregnancy Outcomes. Int J Womens Health. 2016; 8: 265-72.
17. Franco AS, Iuamoto LR, Pereira RMR. Perioperative Management of Drugs Commonly Used in Patients with Rheumatic Diseases: A Review. Clinics. 2017; 72(6): 386-90.
18. Tian X, Zhao J, Song Y, Wang Q, Li M, Liu J, Zeng X. 2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus. Rheumatol Immunol Res. 2023 Sep 27;4(3):115-138. doi: 10.2478/rir-2023-0019.